In metastatic prostate cancer (PCa), DAB2IP expression is often down-regulated and results in PI3K/Akt activation and ASK1-JNK inactivation leading to accelerated PCa growth [40]. This evidence concerns the gene AKT1 and metastatic prostate carcinoma.